Stephen J. Garry & Associates, LLC Anixa Biosciences Inc Transaction History
Stephen J. Garry & Associates, LLC
- $108 Billion
- Q4 2024
A detailed history of Stephen J. Garry & Associates, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Stephen J. Garry & Associates, LLC holds 10,080 shares of ANIX stock, worth $31,651. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,080Holding current value
$31,651% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
60Shares Held
5.61MCall Options Held
21KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.37 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.11 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.95 Million0.21% of portfolio
-
Ubs Group Ag534KShares$1.68 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.47 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $96.3M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...